thymoquinone has been researched along with Diabetic Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aktas, I; Gur, FM | 1 |
| Abdel-Daim, MM; Al Jaouni, SK; Atta, MS; El-Far, AH; Farrag, FA; Mousa, SA | 1 |
| Jiang, YN; Li, N; Liu, H; Liu, HY | 1 |
3 other study(ies) available for thymoquinone and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
The ameliorative effects of thymoquinone and beta-aminoisobutyric acid on streptozotocin-induced diabetic cardiomyopathy.
Topics: Aminoisobutyric Acids; Animals; Benzoquinones; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Male; Rats; Rats, Sprague-Dawley | 2021 |
Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats.
Topics: Animals; Antioxidants; Benzoquinones; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2018 |
Protective effect of thymoquinone improves cardiovascular function, and attenuates oxidative stress, inflammation and apoptosis by mediating the PI3K/Akt pathway in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzoquinones; Blood Glucose; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Evaluation, Preclinical; Inflammation; Male; Malondialdehyde; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |